======= HOXA4 ======= == Gene Information == * **Official Symbol**: HOXA4 * **Official Name**: homeobox A4 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3201|3201]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q00056|Q00056]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HOXA4&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HOXA4|Open PubMed]] * **OMIM**: [[https://omim.org/entry/142953|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Binds to sites in the 5'-flanking sequence of its coding region with various affinities. The consensus sequences of the high and low affinity binding sites are 5'-TAATGA[CG]-3' and 5'-CTAATTTT- 3'. |Homeobox| |activating transcription factor binding| |embryonic skeletal system morphogenesis| |embryonic skeletal system development| |anterior/posterior pattern specification| |skeletal system morphogenesis| |nuclear body| |embryonic organ morphogenesis| |RNA polymerase II regulatory region sequence-specific DNA binding| |regionalization| |embryonic organ development| |pattern specification process| |DNA-binding transcription activator activity, RNA polymerase II-specific| |skeletal system development| |embryonic morphogenesis| |chordate embryonic development| |embryo development ending in birth or egg hatching| |animal organ morphogenesis| |embryo development| |positive regulation of transcription by RNA polymerase II| |positive regulation of transcription, DNA-templated| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of RNA metabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|1.81| |[[:results:exp111|R-DABN 8μM R03 exp111]]|1.95| |[[:results:exp64|Nocodazole 0.2μM R02 exp64]]|1.96| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|2.09| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|2.52| |[[:results:exp93|DABN racemic mixture R03 exp93]]|2.53| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6773 * **Expression level (log2 read counts)**: -7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}